CompletedNot Applicable

Probiotic LR08 Improves Gut and Metabolism

China48 participantsStarted 2025-03-10

Plain-language summary

Evaluate the efficacy and safety of LR08 as a dietary supplement compared to a placebo in enhancing intestinal health and immune function in healthy adults.

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Willing to attend 3 follow-up visits during the intervention period
✓. Agree to provide blood, urine, and stool samples twice during the intervention period
✓. Good eyesight, able to read and write, and capable of wearing glasses if needed
✓. Good hearing and able to fully comprehend all instructions during the intervention

Exclusion criteria

✕. Presence of digestive diseases, particularly gastrointestinal disorders (e.g., celiac disease, ulcerative colitis, Crohn's disease)
✕. History of serious neurological conditions (e.g., epilepsy, stroke, severe head trauma, meningitis within the last 10 years, brain surgery, brain tumor, or prolonged coma-not including general anesthesia)
✕. History of or currently receiving treatment for mental health disorders such as alcohol/drug/substance abuse, schizophrenia, psychosis, or bipolar disorder
✕. Currently taking medication for depression or low mood
✕. Presence of internal organ failure (e.g., heart, liver, or kidney failure)
✕. History of radiation therapy or chemotherapy treatments
✕. Underwent general anesthesia within the past three years or are scheduled for general anesthesia within the next 3 months during the trial period
✕. History of hepatitis (B or C), HIV, or syphilis

What they're measuring

Changes in Immune Function

Timeframe: Week 0 and Week 8

Trial details

NCT IDNCT06875362

SponsorWecare Probiotics Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-05-30

View on ClinicalTrials.gov More Healthy Adults trials